- Home
- CPAC vs SANA Comparison
CPAC vs SANA Comparison
Compare CPAC & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAC
- SANA
- Stock Information
- Founded
- CPAC 1949
- SANA 2018
- Country
- CPAC Peru
- SANA United States
- Employees
- CPAC N/A
- SANA N/A
- Industry
- CPAC Building Materials
- SANA Medicinal Chemicals and Botanical Products
- Sector
- CPAC Industrials
- SANA Health Care
- Exchange
- CPAC Nasdaq
- SANA Nasdaq
- Market Cap
- CPAC 505.3M
- SANA 519.8M
- IPO Year
- CPAC 2012
- SANA 2021
- Fundamental
- Price
- CPAC $5.81
- SANA $1.63
- Analyst Decision
- CPAC Sell
- SANA Strong Buy
- Analyst Count
- CPAC 1
- SANA 5
- Target Price
- CPAC $6.00
- SANA $9.50
- AVG Volume (30 Days)
- CPAC 3.1K
- SANA 3.8M
- Earning Date
- CPAC 04-28-2025
- SANA 05-07-2025
- Dividend Yield
- CPAC 8.63%
- SANA N/A
- EPS Growth
- CPAC 17.75
- SANA N/A
- EPS
- CPAC 0.12
- SANA N/A
- Revenue
- CPAC $524,464,683.00
- SANA N/A
- Revenue This Year
- CPAC N/A
- SANA N/A
- Revenue Next Year
- CPAC N/A
- SANA N/A
- P/E Ratio
- CPAC $9.51
- SANA N/A
- Revenue Growth
- CPAC 1.44
- SANA N/A
- 52 Week Low
- CPAC $5.10
- SANA $1.48
- 52 Week High
- CPAC $6.65
- SANA $10.50
- Technical
- Relative Strength Index (RSI)
- CPAC 54.59
- SANA 33.34
- Support Level
- CPAC $5.71
- SANA $2.18
- Resistance Level
- CPAC $5.95
- SANA $2.43
- Average True Range (ATR)
- CPAC 0.03
- SANA 0.26
- MACD
- CPAC 0.01
- SANA -0.08
- Stochastic Oscillator
- CPAC 100.00
- SANA 9.84
About CPAC Cementos Pacasmayo S.A.A. (Each representing five)
Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.